Эта страница была переведена автоматически, точность перевода не гарантируется. Пожалуйста, обратитесь к английской версии для исходного текста.

Multidomain Approach Through Biopsychosocial Pathways (MAP) Intervention for Older Adults With Age-Related Hearing Loss

11 ноября 2026 г. обновлено: The Hong Kong Polytechnic University

Development and Preliminary Evaluation of a Multidomain Approach Through Biopsychosocial Pathways (MAP) Intervention for Older Adults With Age-Related Hearing Loss: Pilot Randomized Controlled Trial

Background With population aging accelerating worldwide, age-related hearing loss (ARHL) has become one of the most prevalent sensory impairments among older adults, with global prevalence rising from 12.7% at age 60 to over 58% by age 90. The communication difficulties, reduction in daily-life activities, and social stigma associated with hearing loss can contribute to increased loneliness in older adults. This condition affects approximately 25% of older adults in mainland China and 46% in Hong Kong and is associated with depression, increased mortality risk, and elevated healthcare utilization. Addressing loneliness in this population is therefore essential not only for older adults' own health and wellbeing, but also for promoting healthy aging and sustainable community-based care. However, limited studies have examined the associations between loneliness and physical, psychosocial, and hearing health status among older adults with ARHL in real-life living environments and no qualitative study has explored their perceptions and experiences of loneliness. The built environment may influence both hearing health and loneliness among older adults by shaping communication opportunities, social participation, mobility, and access to supportive resources. Therefore, examining the relationships among loneliness, hearing difficulties, and the built environment is important for understanding how everyday living contexts contribute to or mitigate loneliness in later life. Furthermore, existing intervention studies have concentrated mainly on hearing aids and cochlear implants. However, loneliness in this population arises not only from reduced auditory input, but also from psychological distress, social exclusion, and limited opportunities for social engagement, all of which are factors that hearing correction alone cannot directly resolve. These gaps limit the evidence base needed to understand and address loneliness in this population and hinder the development of multi-component interventions for older adults with ARHL.

Aim This study aims 1) to explore the perceptions and experiences of loneliness and social engagement among older adults with ARHL; 2) to examine the associations between loneliness and physical, psychosocial, hearing health, and built environment factors; and 3) to develop and preliminarily evaluate a Multidomain Approach through Biopsychosocial Pathways (MAP) intervention to address loneliness in this population.

Methods A sequential exploratory mixed methods design was adopted, underpinned by the Socio-Ecological Model. This study will be conducted in three phases. First, a qualitative descriptive methodology was used among community-dwelling older adults with ARHL to explore their perceptions and experiences of loneliness and social engagement. Second, a cross-sectional study, with GIS-based spatial analysis will be conducted to examine the associations between loneliness and physical, psychosocial, hearing health, and built-environment factors. Last, a pilot randomized controlled trial will be conducted to evaluate the feasibility, acceptability, and preliminary effects of MAP, underpinned by the biopsychosocial model and findings of previous phases to reduce loneliness among older adults with ARHL.

Expected outcomes This study is expected to 1) provide in-depth qualitative evidence on the perceptions and experiences of loneliness and social engagement among older adults with ARHL; 2) identify multilevel correlates of loneliness, spanning physical, psychosocial, hearing health, and built environment factors; 3) evaluate the feasibility, acceptability, and preliminary effects of MAP on loneliness, thereby informing the design of a future definitive trial and community-based service planning for this population.

Обзор исследования

Тип исследования

Интервенционный

Регистрация (Оцененный)

60

Фаза

  • Непригодный

Контакты и местонахождение

В этом разделе приведены контактные данные лиц, проводящих исследование, и информация о том, где проводится это исследование.

Контакты исследования

Критерии участия

Исследователи ищут людей, которые соответствуют определенному описанию, называемому критериям приемлемости. Некоторыми примерами этих критериев являются общее состояние здоровья человека или предшествующее лечение.

Критерии приемлемости

Возраст, подходящий для обучения

60 лет и старше (Взрослый, Пожилой взрослый)

Принимает здоровых добровольцев

Нет

Полы, имеющие право на обучение

Все

Описание

Inclusion Criteria:

  1. aged 60 years or older and living in the community;
  2. mild-to-moderate hearing loss, defined as a pure-tone average (PTA) of 20-50 dB across octave frequencies from 0.5 to 4 kHz in both ears;
  3. experiencing loneliness (De Jong Loneliness Scale score ≥ 3);
  4. willingness and ability to provide informed consent and comply with study procedures.

Exclusion Criteria:

  1. a history of psychosis, mania, bipolar disorder, substance use disorder, or suicidal ideation;
  2. severe or unstable medical illness;
  3. significant retro cochlear pathology or an organic lesion causing hearing loss;
  4. a diagnosis of probable Alzheimer disease, vascular dementia, frontotemporal dementia, or Parkinson disease;
  5. regular engagement in mindfulness or other mind-body practices (>2 times weekly).

Учебный план

В этом разделе представлена ​​подробная информация о плане исследования, в том числе о том, как планируется исследование и что оно измеряет.

Как устроено исследование?

Детали дизайна

  • Основная цель: Поддерживающая терапия
  • Распределение: Рандомизированный
  • Интервенционная модель: Параллельное назначение
  • Маскировка: Двойной

Оружие и интервенции

Группа участников / Армия
Вмешательство/лечение
Экспериментальный: Multidomain Approach through Biopsychosocial Pathways (MAP) intervention

The intervention group will receive a Multidomain Approach through Biopsychosocial Pathways (MAP) intervention comprising self-administered auricular acupressure, video-guided mindfulness practice adapted from Mindfulness-Based Stress Reduction (MBSR), and a GIS-guided community engagement programme, delivered concurrently over an 8-week period.

The intervention group will receive a Multidomain Approach through Biopsychosocial Pathways (MAP) intervention comprising self-administered auricular acupressure, video-guided mindfulness practice adapted from Mindfulness-Based Stress Reduction (MBSR), and a GIS-guided community engagement programme, delivered concurrently over an 8-week period.

Плацебо Компаратор: Control group

The control group will receive reading materials on ARHL, loneliness, and hearing health education. The control group will receive delayed access to the Multidomain Approach through Biopsychosocial Pathways (MAP) intervention after completion of the final follow-up assessment.

The control group will receive reading materials on ARHL, loneliness, and hearing health education. The control group will receive delayed access to the Multidomain Approach through Biopsychosocial Pathways (MAP) intervention after completion of the final follow-up assessment.

Что измеряет исследование?

Первичные показатели результатов

Мера результата
Мера Описание
Временное ограничение
Adherence to the three intervention components
Временное ограничение: Throughout the 8-week intervention period

Intervention adherence rates for the three components (Auricular acupressure self-administration, completion rate of weekly video-guided mindfulness sessions, and engagement with the GIS-guided community engagement programme) will be assessed using self-reported logs completed independently by older participants via paper booklets. For each component, adherence will be calculated as the number of completed sessions divided by the total number of prescribed sessions during the 8-week intervention period, multiplied by 100. Scores range from 0% to 100%, with higher percentages indicating greater adherence to the respective intervention schedule.

Throughout the 8-week intervention period
Usage Frequency to the three intervention components
Временное ограничение: Throughout the 8-week intervention period

The adherence to the three intervention components was assessed using self-reported logs completed independently by older participants via paper booklets. A usage session was defined as one recorded episode of engaging in each respective activity. Adherence for each component was quantified as the mean number of sessions completed per week across the 8-week intervention period, with higher values indicating more frequent engagement.

Throughout the 8-week intervention period
Participant retention rate
Временное ограничение: Week 8

The participant retention rate will be calculated as the number of enrolled participants who remain in the study and have not withdrawn by Week 8 divided by the total number of participants enrolled, multiplied by 100. Scores range from 0% to 100%, with higher percentages indicating greater participant retention.

Week 8
The follow-up assessment completion rate
Временное ограничение: Week 8

The follow-up assessment completion rate will be calculated as the number of participants who complete the scheduled Week 8 follow-up assessment divided by the total number of enrolled participants expected to complete the assessment, multiplied by 100. Scores range from 0% to 100%, with higher percentages indicating greater follow-up completion.

Week 8
Acceptability of the intervention assessed by semi-structured interviews
Временное ограничение: Week 8, following completion of the intervention

All participants in the intervention group will be invited to take part in an individual interview after completing the intervention, to explore their experiences of participating in the Multidomain Approach through Biopsychosocial Pathways (MAP) intervention and their perceptions of its acceptability. Interview data will be analyzed using thematic analysis and reported as themes and subthemes related to participants' experiences and perceived acceptability. No numerical scale score will be calculated.

Week 8, following completion of the intervention

Вторичные показатели результатов

Мера результата
Мера Описание
Временное ограничение
Loneliness
Временное ограничение: Baseline and Week 8

Loneliness will additionally be assessed as a preliminary indicator of intervention effect. This is the outcome proposed as the primary outcome for a future definitive trial. Change in loneliness from baseline to post-intervention will be measured using the Mandarin version of the 6-item De Jong Gierveld Loneliness Scale (DJGLS).

Baseline and Week 8
Sleep quality
Временное ограничение: Baseline and Week 8

Sleep quality will be assessed using the Chinese version of the Pittsburgh Sleep Quality Index (CPSQI), administered at baseline and post-intervention.

Baseline and Week 8
Subjective hearing difficulty
Временное ограничение: Baseline and Week 8

Subjective hearing difficulty will be measured using the 18-item Revised Hearing Handicap Inventory (R-HHI), administered at baseline and post-intervention.

Baseline and Week 8
Depressive symptoms
Временное ограничение: Baseline and Week 8

Depressive symptoms will be screened with the Patient Health Questionnaire-2 (PHQ-2), administered at baseline and post-intervention.

Baseline and Week 8
Community resource utilization
Временное ограничение: Baseline and Week 8

As no validated instrument exists for this intervention-specific component, a study-designed weekly tick-box log will be used to record visits to GIS-recommended resources (hearing service centers or community/green space facilities), with participants choosing a paper or electronic format based on preference. Logs will be submitted at the post-intervention assessment, with paper records transcribed into the same database as electronic entries. The primary metric will be the cumulative number of resource visits over the intervention period.

Baseline and Week 8

Соавторы и исследователи

Здесь вы найдете людей и организации, участвующие в этом исследовании.

Даты записи исследования

Эти даты отслеживают ход отправки отчетов об исследованиях и сводных результатов на сайт ClinicalTrials.gov. Записи исследований и сообщаемые результаты проверяются Национальной медицинской библиотекой (NLM), чтобы убедиться, что они соответствуют определенным стандартам контроля качества, прежде чем публиковать их на общедоступном веб-сайте.

Изучение основных дат

Начало исследования (Оцененный)

1 декабря 2026 г.

Первичное завершение (Оцененный)

1 января 2028 г.

Завершение исследования (Оцененный)

30 июня 2028 г.

Даты регистрации исследования

Первый отправленный

11 ноября 2026 г.

Впервые представлено, что соответствует критериям контроля качества

11 ноября 2026 г.

Первый опубликованный (Действительный)

17 ноября 2026 г.

Обновления учебных записей

Последнее опубликованное обновление (Действительный)

17 ноября 2026 г.

Последнее отправленное обновление, отвечающее критериям контроля качества

11 ноября 2026 г.

Последняя проверка

1 августа 2026 г.

Дополнительная информация

Термины, связанные с этим исследованием

Планирование данных отдельных участников (IPD)

Планируете делиться данными об отдельных участниках (IPD)?

НЕТ

Информация о лекарствах и устройствах, исследовательские документы

Изучает лекарственный продукт, регулируемый FDA США.

Нет

Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.

Нет

Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .

Подписаться